Cvs Health Corp Stock Price, News & Analysis

CVS (NYSE: CVS) announced that its board approved a quarterly dividend of $0.665 per share on common stock.

The dividend is payable on February 2, 2026 to holders of record as of January 22, 2026.

CVS (NYSE:CVS) announced on Dec 11, 2025 that it is offering the measles-mumps-rubella (MMR) vaccine to South Carolina residents amid the state's current measles outbreak. More than 200 CVS Pharmacy and MinuteClinic locations across South Carolina will provide MMR vaccinations for patients ages 3 and older; MinuteClinic also provides the recommended second dose for children ages 4–6.

The MMR vaccine may provide some protection if given within 72 hours of exposure. Walk-ins are accepted at pharmacies, but appointments are encouraged via CVS.com, the CVS Health app, or MinuteClinic.com. Pharmacy and clinic staff can help check insurance coverage and determine immunity status.

CVS Health (NYSE: CVS) updated 2025 guidance, provided 2026 guidance, and outlined a multi-year growth plan at its 2025 Investor Day on Dec 9, 2025. The company raised 2025 revenue guidance to at least $400.0B, raised adjusted operating income guidance to $14.22B–$14.39B, and confirmed 2025 cash flow from operations of $7.5B–$8.0B. CVS initiated 2026 guidance with revenue of at least $400.0B, adjusted operating income of $15.07B–$15.41B, adjusted EPS of $7.00–$7.20, and at least $10.0B cash flow from operations.

The company expects a mid‑teens adjusted EPS CAGR through 2028, announced an AI‑native open consumer engagement platform, and reiterated strategic focus across Aetna, CVS Caremark, CVS Pharmacy, and Health Care Delivery.

CVS (NYSE: CVS) released its inaugural National Economic Impact Report on Dec 5, 2025, saying its operations deliver an annual $474 billion economic impact across the U.S. and support 1.3 million jobs nationwide.

The report cites 300,000+ employees, approximately 9,000 retail pharmacy locations and >1,000 walk-in and primary care clinics, serving 185 million individuals and placing nearly 85% of Americans within 10 miles of a CVS pharmacy.

Other metrics include $58.6 billion in local, state and federal taxes, $239 million in community investments, and 84,000 volunteer hours. The report uses IMPLAN-based analysis by Parker Strategy Group.

Aetna (NYSE: CVS) announced December 4, 2025 updates that simplify prior authorization, expand clinical collaboration, and add AI capabilities to the Aetna Health app.

Key actions: effective November 2025 Aetna now bundles medical and pharmacy prior authorizations for certain conditions (examples: IVF, musculoskeletal bundles including X-rays, THA/TKA, specified meds and DME). The Aetna Clinical Collaboration (ACC) program is live in 17 hospitals and is projected to reduce 30-day readmissions and length of stay by 5% when fully implemented. As part of CVS Health's $20 billion multi-year digital investment, generative AI features have launched to an initial population and will expand in early 2026.

Cornerstone Community Development, together with Winterwood and CVS Health (NYSE: CVS), will host the Prichard Centennial Residential Reveal & Next-Phase Preview on December 4, 2025 at 1:30 p.m. in Huntington, WV.

The event showcases newly completed residential spaces inside the historic Prichard building and previews the next restoration phase. CVS Health has invested more than $17 million in the Prichard adaptive-reuse and has invested over $21 million in affordable housing across West Virginia, helping create or preserve 800+ affordable units.

CVS Health (NYSE: CVS) announced that its Board elected President and CEO David Joyner as Chair of the Board, effective January 1, 2026. Michael Mahoney will remain the Board's Lead Independent Director, and Roger Farah will continue to serve on the Board after stepping down from Executive Chair.

Joyner was named President and CEO in October 2024 and the Board cited his nearly 40 years of industry experience and a year of operational, financial and cultural improvements. The company noted its workforce of more than 300,000 colleagues and said the combined Chair and CEO structure aims to support execution of long-term strategy and stockholder value.

CVS (NYSE:CVS) announced on November 20, 2025 the launch of Joyward, a new owned brand of seasonal decor, gifts and home accents available in stores and online for the 2025 holiday season.

The initial Joyward Holiday 2025 Collection includes throws, pillows, nutcrackers, ceramic trees, curated gift sets and accessories. Joyward will expand in 2026 with new seasonal collections and trending designs. Joyward integrates with CVS fulfillment options and loyalty programs, including same-day delivery and ExtraCare/ExtraCare+ offers.

Aetna (NYSE: CVS) launched a generative AI-powered conversational assistant embedded across its website and mobile app to simplify member navigation of benefits and care. The assistant provides plain-language answers, session-aware guidance, and dynamically generated rich UI components (maps, charts, financial breakdowns) for personalized, visual responses.

The capability entered a beta in October 2025 and access will expand through late 2025 and the first half of 2026, with full voice enablement and multimodal support (voice, text, screen reader) planned in H1 2026. The assistant will integrate with Aetna's patent-pending Care Paths to offer proactive, contextual recommendations.